COMMUNIQUÉS West-GlobeNewswire

The Joint Corp. Reports 2024 Operating Metrics

16/01/2025 - 13:05

- Adjustments Performed in 2024 Grows 9%, Compared to 2023 - - Receives Letters of Intent for the majority of the Corporate Portfolio in Early January 2025 - SCOTTSDALE, Ariz., Jan. 16, 2025 (GLOBE NEWSWIRE) -- The [...]

Avacta Announces Positive New Data from the AVA6000 Phase 1 trial Demonstrating Clinically Meaningful Tumor Shrinkage in Patients with Salivary Gland Cancers

16/01/2025 - 13:00

Meaningful tumor shrinkage observed in five out of 10 patients with partial and minor responses and 90% disease control rate in patients with salivary gland cancers Phase 1b expansion cohorts screening patients in [...]

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

16/01/2025 - 13:00

WATERTOWN, Mass., Jan. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious [...]

Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale

16/01/2025 - 13:00

CAMBRIDGE, Mass., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, announced today the receipt of a $50 million installment [...]

Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines

16/01/2025 - 13:00

$16M extension round led by J2 Ventures and GHIC builds on support from BARDA, CEPI, the Bill & Melinda Gates Foundation and others to simplify access to life-saving drugs ATLANTA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- [...]

Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial

16/01/2025 - 12:00

ONS-5010 demonstrated to be non-inferior to Lucentis at 12 weeks BLA resubmission on track for calendar Q1 2025 Entered into agreements for warrant inducement transaction expected to result in up to $20.4 million in [...]

KFSHRC Launches Precision Medicine Services in Family Medicine Clinics to Enhance Access to the Latest Genetic Tests

16/01/2025 - 10:52

RIYADH, Saudi Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has launched precision medicine services within its Family Medicine Clinics, aiming to advance [...]

Actimed Therapeutics appoints Dr Fabio Dorigotti as Chief Medical Officer to drive further pipeline development for cancer cachexia and other muscle wasting disorders

16/01/2025 - 09:00

Fabio Dorigotti brings over 25 years of clinical development experience Joins Actimed following retirement of Frank Misselwitz London, UK – 16 January 2025. Actimed Therapeutics, a UK based clinical stage speciality [...]

Phonak expands award-winning Infinio portfolio with two new custom hearing aids

16/01/2025 - 08:00

Phonak, a leading global provider of life-changing hearing solutions, is proud to announce the expansion of its highly acclaimed Infinio technology platform with the introduction of two new in-the-ear (ITE) hearing aids [...]

Santhera Receives Positive NICE Final Guidance for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy

16/01/2025 - 07:00

Santhera has begun launch preparations for AGAMREE® in UK with first sales expected in this quarter Pratteln, Switzerland, January 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that the National Institute [...]

Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76

14/01/2025 - 22:58

CTIM-76 Phase 1 trial focused on CLDN6-positive gynecologic and testicular cancers Trial marks key milestone in driving pipeline progress PHILADELPHIA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“ [...]

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue

14/01/2025 - 22:15

Fourth quarter 2024 total revenue expected to be a record at approximately $8.2 million, representing growth of approximately 30% compared to the prior-year period. Fourth quarter 2024 recurring revenue expected to be [...]

Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules

14/01/2025 - 22:15

FARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced that it was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance [...]

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

14/01/2025 - 22:05

Full-Year 2024 Total Revenue Growth of 20% and Adjusted EBITDA Growth of Approximately 55% MACI Full-Year 2024 Revenue Growth of 20%, with Fourth Quarter Revenue of $68.2 to $68.7 Million Highest Quarterly MACI Implants [...]

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

14/01/2025 - 22:05

BRISBANE, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting of a non-qualified [...]

Evaxion announces completion of ADS ratio change

14/01/2025 - 22:05

COPENHAGEN, Denmark, January 14, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that [...]

OP Solutions Appoints Michael Kallish as Chief Executive Officer

14/01/2025 - 20:00

Experienced HIT Executive to Lead Next Stage of Growth for Orthotic & Prosthetic EMR Provider Tampa, Jan. 14, 2025 (GLOBE NEWSWIRE) -- OP Solutions , the emerging leader in comprehensive technology solutions for [...]

UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles

14/01/2025 - 19:59

U.S. Department of Health and Human Services (HHS) office, BARDA, awards Micron $2 million to continue its work on broadly-protecting avian and seasonal flu vaccines SAN FRANCISCO, Jan. 14, 2025 (GLOBE NEWSWIRE) -- [...]

EssilorLuxottica: Déclaration de transactions sur actions propres

14/01/2025 - 18:00

Déclaration de transactions sur actions propres Paris, France (14 janvier 2025, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 7 janvier 2025 [...]